Details of the Drug

General Information of Drug (ID: DMTTXCF)

Drug Name
ABC008
Indication
Disease Entry ICD 11 Status REF
Inclusion body myositis 4A41.2 Phase 2/3 [1]
Drug Type
Monoclonal antibody
Cross-matching ID
TTD ID
D3WA2V

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Killer cell lectin-like receptor subfamily G member 1 (KLRG1) TT299E6 KLRG1_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05721573) A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABC008 in the Treatment of Subjects With Inclusion Body Myositis. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Abcuro